<?xml version="1.0" encoding="UTF-8"?>
<p id="par0070">Antibodies that neutralize SARS-CoV predominantly bind to the RBD of Spike. Rockx 
 <italic>et al.</italic> selected and sequenced a number of different escape mutants to a panel of 23 human monoclonal antibodies, the majority of which contained single substitutions along the RBD interface with ACE2 [
 <xref rid="bib0315" ref-type="bibr">63
  <sup>••</sup>
 </xref>]. All but one escape site mapped within 4 angstroms of contact interface residues, and yet all viruses grew to comparable peak titers in Vero and hACE2-restricted DBT cells. However, growth on civet-ACE2-restricted DBT cells was restricted for all escape viruses, suggesting that escape from antibody neutralization can alter Spike–receptor binding and, consequently, host range [
 <xref rid="bib0315" ref-type="bibr">63
  <sup>••</sup>
 </xref>]. That antibody escape variants can stably adopt substitutions in the Spike–ACE2 receptor interface suggests that the host response to an infection may select for host range variants by a mutation-driven mechanism.
</p>
